Insulin Degludec and Glargine U100 for Management of Hospitalized and Discharged Patients With Type 2 Diabetes

NCT03336528 PHASE4 COMPLETED Results posted

The purpose of this study is to find out if treatment with degludec insulin when compared to glargine U100 insulin will result in similar blood sugar control in patients with diabetes who are admitted to the hospital and then transition to home after discharge from the hospital.

Details

Lead sponsor	Emory University
Phase	PHASE4
Status	COMPLETED
Enrolment	180
Start date	Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Mar 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Type 2 Diabetes

Interventions

• Degludec
• Glargine
• Aspart

Countries

United States